Literature DB >> 33826127

Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[18F]F PET-CT.

João Borges-Rosa1, Manuel Oliveira-Santos2,3,4,5, Rodolfo Silva3,4,5, Nuno Pereira da Silva6, Antero Abrunhosa3,4,5, Miguel Castelo-Branco3,4,5, Lino Gonçalves2,4,7, Maria João Ferreira2,3,4,5.   

Abstract

BACKGROUND: Fluorine-18 sodium fluoride (Na[18F]F) atherosclerotic plaque uptake in positron emission tomography with computed tomography (PET-CT) identifies active microcalcification. We aim to evaluate global cardiac microcalcification activity with Na[18F]F, as a measure of unstable microcalcification burden, in high cardiovascular (CV) risk patients. METHODS AND
RESULTS: Thirty-four high CV risk individuals without previous CV events were scanned with Na[18F]F PET-CT. Cardiac Na[18F]F uptake was assessed through the global molecular calcium score (GMCS), which was calculated by summing the product of the mean standardized uptake value times the area of the cardiac regions of interest times the slice thickness for all cardiac transaxial slices, divided by the total number of slices. Mean age is 63.5 ± 7.8 years and 62% male. Median GMCS is 320.9 (240.8-402.8). Individuals with more than five CV risk factors (50%) have increased GMCS [356.7 (321.0-409.6) vs. 261.1 (225.6-342.1), P = 0.01], which is positively correlated with predicted fatal CV risk by SCORE (rs = 0.32, P = 0.04). There is a positive correlation between GMCS and weight (rs = 0.61), body mass index (rs = 0.66), abdominal perimeter (rs = 0.74), thoracic fat volume (rs = 0.47), and epicardial adipose tissue (rs = 0.41), all with P ≤ 0.01. There is no correlation between GMCS and coronary calcium score nor coronary artery wall Na[18F]F uptake.
CONCLUSIONS: In a high CV risk group, the global cardiac microcalcification burden is related to CV risk factors, metabolic syndrome variables and cardiac fat. Cardiac GMCS is a promising risk stratification tool, combining a straightforward and objective methodology with a comprehensive analysis of both coronary and valvular microcalcification.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33826127     DOI: 10.1007/s12350-021-02600-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  4 in total

1.  Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept.

Authors:  Mohsen Beheshti; Babak Saboury; Nehal N Mehta; Drew A Torigian; Tom Werner; Emile Mohler; Robert Wilensky; Andrew B Newberg; Sandip Basu; Werner Langsteger; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2011 May-Aug       Impact factor: 1.102

Review 2.  Epicardial and thoracic fat - Noninvasive measurement and clinical implications.

Authors:  Damini Dey; Ryo Nakazato; Debiao Li; Daniel S Berman
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

3.  Role of 18F-NaF-PET in assessing aortic valve calcification with age.

Authors:  Chaitanya Rojulpote; Austin J Borja; Vincent Zhang; Mahmoud Aly; Benjamin Koa; Siavash M Seraj; William Y Raynor; Esha Kothekar; Fatemeh Kaghazchi; Thomas J Werner; Oke Gerke; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

4.  Sodium fluoride in cardiovascular disorders: A systematic review.

Authors:  Beatriz Isabel Silva Mendes; Manuel Oliveira-Santos; Maria João Vidigal Ferreira
Journal:  J Nucl Cardiol       Date:  2019-08-06       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.